Universe Pharmaceuticals INC (UPC) Balance Sheet
UPC balance sheet, FY2025
September 30, 2025 · U.S. dollars$69.3M assets = $13.2M liabilities + $56.1M equity
Both columns are drawn to the same scale: what UPC owns equals what it owes plus shareholders’ equity. Hover a block for its value.
UPC financial health
Descriptive bands, not a rating. Fiscal FY2025.
UPC balance sheet trends, FY2018–FY2025
| Metric | Trend | Then | Latest | Change |
|---|---|---|---|---|
| Total assets | $28.1MFY2018 | $69.3MFY2025 | +13.8%/yr | |
| Total liabilities | $18.4MFY2018 | $13.2MFY2025 | −4.7%/yr | |
| Shareholders’ equity | $9.7MFY2018 | $56.1MFY2025 | +28.5%/yr | |
| Cash & short-term investments | $6.2MFY2018 | $33.6MFY2025 | +27.3%/yr | |
| Total debt | $2.6MFY2018 | $9.3MFY2025 | +19.8%/yr | |
| Net cash (debt) | $3.6MFY2018 | $24.3MFY2025 | +$20.8M | |
| Working capital | $3.6MFY2018 | $40.4MFY2025 | +$36.9M | |
| Current ratio | 1.19FY2018 | 4.07FY2025 | +2.88 | |
| Debt / equity | 0.27FY2018 | 0.16FY2025 | −0.11 |
Change is the average annual growth (CAGR) or the difference between the first and latest year.
UPC assets
UPC liabilities and equity
UPC debt vs cash
Debt includes short- and long-term borrowings and, where reported, lease obligations.
UPC balance sheet
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & short-term investments | $33.6M | $29.5M | $18.5M | $18.9M | $21.8M | $10.1M | $3.2M | $6.2M |
| Cash & equivalents | $33.6M | $29.5M | $5.3M | $5.7M | $8.1M | $10.1M | $3.2M | $6.2M |
| Short-term investments | — | — | $13.2M | $13.1M | $13.7M | $0 | — | — |
| Receivables | $13.2M | $12.9M | $10.7M | $15.2M | $15.8M | $10.9M | $6.4M | $7.6M |
| Inventory | $2.2M | $1.7M | $3.3M | $2.2M | $2.5M | $1.9M | $2.6M | $8.1M |
| Other current assets | $4.6M | $7.5M | $4.2M | $5.3M | $10.4M | $0 | $16,300 | $8,484 |
| Total current assets | $53.6M | $51.6M | $36.8M | $41.5M | $50.5M | $22.8M | $12.2M | $22.0M |
| Property, plant & equipment (net) | $14.7M | $15.3M | $15.0M | $13.6M | $15.4M | $4.4M | $4.6M | $5.1M |
| Goodwill & intangible assets | $296,785 | $262,878 | $148,584 | $157,451 | $178,483 | $174,776 | $171,610 | $183,583 |
| Long-term investments | $702,346 | $712,494 | $685,307 | $702,890 | $744,924 | $735,000 | $700,500 | $728,000 |
| Other non-current assets | $0 | $0 | $656,980 | $3.6M | $3.3M | $630,246 | $168,075 | $135,021 |
| Total assets | $69.3M | $68.0M | $53.3M | $59.5M | $70.1M | $28.8M | $17.8M | $28.1M |
| Liabilities | ||||||||
| Accounts payable | $1.7M | $4.9M | $4.6M | $3.1M | $5.3M | $2.7M | $1.9M | $2.9M |
| Short-term debt | $9.3M | — | $5.5M | $3.9M | $4.3M | $2.6M | $2.5M | $2.6M |
| Deferred revenue | $40,708 | — | — | — | — | — | — | $893,512 |
| Total current liabilities | $13.2M | $20.3M | $13.8M | $13.1M | $11.2M | $8.0M | $5.5M | $18.4M |
| Long-term debt | $0 | $2.1M | $0 | $0 | $0 | $0 | $0 | $0 |
| Other long-term liabilities | $2.1M | $0 | $0 | $7.0M | $9.6M | $5.3M | $4.5M | $0 |
| Total liabilities | $13.2M | $22.5M | $13.8M | $13.1M | $11.2M | $8.0M | $5.5M | $18.4M |
| Shareholders' equity | ||||||||
| Common stock & paid-in capital | $6.3M | — | $67,969 | $67,969 | $67,969 | $50,000 | $50,000 | $50,000 |
| Retained earnings (deficit) | −$13.8M | −$10.2M | $10.2M | $16.3M | $25.1M | $13.7M | $6.2M | $2.8M |
| Accumulated other comprehensive income | $626,013 | — | $26,269 | $772,830 | $4.5M | $3.3M | $2.5M | $3.1M |
| Total shareholders' equity | $56.1M | $45.5M | $39.5M | $46.4M | $58.9M | $20.8M | $12.4M | $9.7M |
| Key figures | ||||||||
| Total debt | $9.3M | $2.1M | $5.5M | $3.9M | $4.3M | $2.6M | $2.5M | $2.6M |
| Net cash (debt) | $24.3M | $27.4M | $13.0M | $14.9M | $17.5M | $7.4M | $655,521 | $3.6M |
| Working capital | $40.4M | $31.3M | $23.1M | $28.4M | $39.3M | $14.8M | $6.8M | $3.6M |
| Tangible book value | $55.8M | $45.2M | $39.4M | $46.3M | $58.8M | $20.6M | $12.2M | $9.5M |
| Current ratio | 4.07 | 2.54 | 2.68 | 3.17 | 4.50 | 2.85 | 2.24 | 1.19 |
| Quick ratio | 3.55 | 2.09 | 2.13 | 2.60 | 3.36 | 2.62 | 1.76 | 0.75 |
| Debt / equity | 0.16 | 0.05 | 0.14 | 0.08 | 0.07 | 0.13 | 0.20 | 0.27 |
| Equity / assets | 81.0% | 67.0% | 74.2% | 78.0% | 84.0% | 72.2% | 69.4% | 34.5% |
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Mar '25 | Sep '24 | Jun '24 | Mar '24 | Dec '23 | Sep '23 | Jun '23 | Mar '23 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||
| Cash & short-term investments | $29.0M | $29.0M | $33.6M | $33.6M | $47.3M | $29.5M | $11.4M | $11.4M | $18.5M | $18.5M | $26.3M | $26.3M |
| Cash & equivalents | $27.6M | $27.6M | $33.6M | $33.6M | $47.3M | $29.5M | $8.9M | $8.9M | $5.3M | $5.3M | $13.0M | $13.0M |
| Short-term investments | $1.5M | $1.5M | — | — | — | — | $2.5M | $2.5M | $13.2M | $13.2M | $13.3M | $13.3M |
| Receivables | $20.5M | $15.0M | $13.2M | $13.0M | $13.5M | $12.9M | $14.4M | $14.4M | $10.7M | $11.0M | $17.5M | $17.5M |
| Inventory | $4.0M | $2.0M | $2.2M | $2.2M | $4.2M | $1.7M | $3.8M | $3.4M | $3.3M | $3.3M | $2.9M | $2.9M |
| Other current assets | $1.7M | $9.2M | $4.6M | $4.8M | $39,179 | $7.5M | $4.0M | $4.4M | $4.2M | $0 | $5.9M | $5.9M |
| Total current assets | $55.2M | $55.2M | $53.6M | $53.6M | $65.0M | $51.6M | $33.5M | $33.5M | $36.8M | $25.3M | $52.5M | $52.5M |
| Property, plant & equipment (net) | $15.2M | $15.2M | $14.7M | $14.7M | $14.7M | $15.3M | $15.0M | $15.0M | $15.0M | $15.0M | $13.8M | $13.8M |
| Goodwill & intangible assets | $309,750 | $309,750 | $296,785 | $296,785 | $266,783 | $262,878 | $147,652 | $147,652 | $148,584 | $148,584 | $160,470 | $160,470 |
| Long-term investments | $0 | $724,848 | $0 | $702,346 | $689,018 | $712,494 | $0 | $692,492 | $0 | $685,307 | $0 | $728,055 |
| Other non-current assets | $724,848 | $0 | $702,346 | $0 | $0 | $0 | $788,633 | $96,141 | $1.3M | $634,942 | $3.9M | $3.2M |
| Total assets | $71.5M | $71.5M | $69.3M | $69.3M | $80.7M | $68.0M | $49.4M | $49.4M | $53.3M | $41.7M | $70.4M | $70.4M |
| Liabilities | ||||||||||||
| Accounts payable | $3.8M | $3.8M | $1.7M | $1.7M | $7.4M | $4.9M | $7.8M | $7.8M | $4.6M | $4.6M | $11.2M | $11.2M |
| Short-term debt | $7.4M | — | $9.3M | — | $5.7M | — | $4.4M | — | $5.5M | — | $4.1M | $4.1M |
| Deferred revenue | $42,012 | — | $40,708 | — | — | — | $172,374 | — | — | — | — | — |
| Total current liabilities | $13.6M | $13.6M | $13.2M | $13.2M | $23.4M | $20.3M | $20.6M | $20.6M | $13.8M | $13.8M | $23.2M | $23.2M |
| Long-term debt | $0 | $2.2M | $0 | $0 | $2.1M | $2.1M | $0 | $2.1M | $0 | $0 | $0 | $0 |
| Other long-term liabilities | $2.2M | $0 | $0 | $0 | $0 | $0 | $2.1M | $0 | $0 | $0 | $0 | $0 |
| Total liabilities | $15.8M | $15.8M | $13.2M | $13.2M | $25.5M | $22.5M | $22.7M | $22.7M | $13.8M | $13.8M | $23.2M | $23.2M |
| Shareholders' equity | ||||||||||||
| Common stock & paid-in capital | $6 | — | $6.3M | — | $6.3M | — | $68,362 | — | $67,969 | — | $67,969 | $67,969 |
| Retained earnings (deficit) | −$15.4M | −$15.4M | −$13.8M | −$13.8M | −$13.5M | −$10.2M | −$2.9M | −$2.9M | $10.2M | −$1.4M | $15.6M | $15.6M |
| Accumulated other comprehensive income | $1.7M | — | $626,013 | — | −$705,844 | — | $339,121 | — | $26,269 | — | $2.2M | $2.2M |
| Total shareholders' equity | $55.6M | $55.6M | $56.1M | $56.1M | $55.2M | $45.5M | $26.7M | $26.7M | $39.5M | $28.0M | $47.1M | $47.1M |
| Key figures | ||||||||||||
| Total debt | $9.6M | $2.2M | $9.3M | — | $7.7M | $2.1M | $6.5M | $2.1M | $5.5M | — | $4.1M | $4.1M |
| Net cash (debt) | $19.5M | $26.9M | $24.3M | — | $39.5M | $27.4M | $4.9M | $9.3M | $13.0M | — | $22.2M | $22.2M |
| Working capital | $41.6M | $41.6M | $40.4M | $40.4M | $41.6M | $31.3M | $12.9M | $12.9M | $23.1M | $11.5M | $29.3M | $29.3M |
| Tangible book value | $55.3M | $55.3M | $55.8M | $55.8M | $54.9M | $45.2M | $26.6M | $26.6M | $39.4M | $27.8M | $47.0M | $47.0M |
| Book value per share | — | — | — | — | — | — | — | — | — | — | — | $13.00 |
| Shares outstanding | — | — | — | — | — | — | — | — | — | — | — | 3.6M |
| Current ratio | 4.05 | 4.05 | 4.07 | 4.07 | 2.78 | 2.54 | 1.63 | 1.63 | 2.68 | 1.84 | 2.26 | 2.26 |
| Quick ratio | 3.63 | 3.22 | 3.55 | 3.54 | 2.60 | 2.09 | 1.25 | 1.25 | 2.13 | 2.15 | 1.88 | 1.88 |
| Debt / equity | 0.17 | 0.04 | 0.16 | — | 0.14 | 0.05 | 0.24 | 0.08 | 0.14 | — | 0.09 | 0.09 |
| Equity / assets | 77.9% | 77.9% | 81.0% | 81.0% | 68.4% | 67.0% | 54.1% | 54.1% | 74.2% | 67.0% | 67.0% | 67.0% |
Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported (latest annual report filed January 29, 2026); data from EODHD.
UPC financial position
At the end of fiscal 2025 (September 30, 2025), Universe Pharmaceuticals INC had total assets of $69.3 million (up 2.0% from a year earlier), total liabilities of $13.2 million and shareholders' equity of $56.1 million. It held $33.6 million in cash and short-term investments against $9.3 million of debt, a net cash position of $24.3 million. Its current ratio was 4.07. In the latest quarter (ended June 30, 2026) total assets were $71.5 million and equity $55.6 million.
Related: UPC income statement, UPC cash flow statement, UPC key metrics. See the UPC stock overview for the latest quote and news.
UPC balance sheet FAQ
What are Universe Pharmaceuticals INC's total assets?
Universe Pharmaceuticals INC reported total assets of $69.3 million at the end of fiscal 2025 (September 30, 2025), compared with $68.0 million a year earlier.
How much debt does Universe Pharmaceuticals INC have?
Universe Pharmaceuticals INC had $9.3 million of total debt at the end of fiscal 2025, including short-term borrowings. Its debt-to-equity ratio was 0.16.
How much cash does Universe Pharmaceuticals INC have?
Universe Pharmaceuticals INC held $33.6 million in cash and short-term investments at the end of fiscal 2025; with $9.3 million of debt that is net cash of $24.3 million.
What is Universe Pharmaceuticals INC's book value?
Universe Pharmaceuticals INC's shareholders' equity (book value) was $56.1 million at the end of fiscal 2025.
What is Universe Pharmaceuticals INC's current ratio?
Universe Pharmaceuticals INC had current assets of $53.6 million and current liabilities of $13.2 million, a current ratio of 4.07 (it can cover its short-term obligations).
How much goodwill does Universe Pharmaceuticals INC have?
Universe Pharmaceuticals INC carried $0.3 million of goodwill and intangible assets, 0.4% of total assets, at the end of fiscal 2025.